Enanta Pharmaceuticals Inc (ENTA)
9.31
+0.23
(+2.53%)
USD |
NASDAQ |
Nov 21, 16:00
9.30
-0.01
(-0.11%)
After-Hours: 20:00
Enanta Pharmaceuticals Profit Margin (Quarterly): -126.1% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -126.1% |
| March 31, 2024 | -182.7% |
| December 31, 2023 | -185.6% |
| September 30, 2023 | -148.5% |
| June 30, 2023 | -206.8% |
| March 31, 2023 | -211.6% |
| December 31, 2022 | -122.9% |
| September 30, 2022 | -129.7% |
| June 30, 2022 | -162.7% |
| March 31, 2022 | -179.5% |
| December 31, 2021 | -108.9% |
| September 30, 2021 | -104.3% |
| June 30, 2021 | -111.1% |
| March 31, 2021 | -109.5% |
| December 31, 2020 | -26.24% |
| September 30, 2020 | -124.2% |
| June 30, 2020 | -76.48% |
| March 31, 2020 | -21.74% |
| December 31, 2019 | 25.57% |
| September 30, 2019 | 17.91% |
| June 30, 2019 | 15.86% |
| March 31, 2019 | 10.46% |
| December 31, 2018 | 37.22% |
| September 30, 2018 | 40.80% |
| June 30, 2018 | 35.43% |
| Date | Value |
|---|---|
| March 31, 2018 | 28.50% |
| December 31, 2017 | 30.68% |
| September 30, 2017 | 48.08% |
| June 30, 2017 | -112.2% |
| March 31, 2017 | -60.19% |
| December 31, 2016 | -47.81% |
| September 30, 2016 | -14.03% |
| June 30, 2016 | -7.70% |
| March 31, 2016 | -12.65% |
| December 31, 2015 | 54.06% |
| September 30, 2015 | 40.32% |
| June 30, 2015 | 20.85% |
| March 31, 2015 | 50.12% |
| December 31, 2014 | 54.21% |
| September 30, 2014 | -191.2% |
| June 30, 2014 | |
| March 31, 2014 | -240.9% |
| December 31, 2013 | -601.3% |
| September 30, 2013 | -329.4% |
| June 30, 2013 | -250.9% |
| March 31, 2013 | -313.5% |
| December 31, 2012 | 78.81% |
| September 30, 2012 | -218.1% |
| June 30, 2012 | -137.7% |
| March 31, 2012 | 87.82% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-211.6%
Minimum
Mar 2023
25.57%
Maximum
Dec 2019
-121.7%
Average
-124.2%
Median
Sep 2020
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -59.98% |
| Return on Assets | -26.23% |
| Return on Invested Capital | -59.98% |
| Operating Margin (Quarterly) | -134.6% |
| Return on Net Operating Assets | -133.0% |